References
- Eldor A, Maclouf J, Lellouche F, Ben Yashar V, et al. A chronic hypercoagulable state and lifelong platelet activation in beta thalassemia major. Southeast Asian J Trop Med Public Health 1993;24( Suppl):92–95.
- Eldor A, Kraust Y, Allan H, Snyde D, Goldfarb A, et al. Platelet survival in patients with beta thalassemia. Am J Hematol 1993;44:63–65.
- Helley D, Eldor A, Girot R, Ducrocq R, Guillin M, et al. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and beta thalassemia. Thromb Haemost 1996;76:322–327.
- Ruf A, Pick M, Deutsch V, Patsheke H, Goldfarb A, et al. In vivo platelet activation correlates with red cell anionic phospholipids exposure in patients with beta-thalassemia major. Br J Hematol 1997;98:51–56.
- Andrew M, Manno M, Karpatkin M. Demonstration of Kallikrein-like protaease activity in nonactivated plasma of patients with Cooley's anemia. Blood 1998;61:232-237.
- Sinniah D, Bosco T, Kamaruddin A. Prednisolone therapy for lupus anticoagulant in beta thalassemia major. Singapore Med J 1984;25: 77–79.
- Ibrahim CP. Haemostatic derangements and lupus antic-oagulant in polytransfused patients of 3-thalassemia major. Asian J Paediatr Pract 1999;3:31–38.
- Hejmadi A. Study of coagulation profile: Role of lupus anticoagulant in multitransfused thalassemic children Abstracts of 34th national conference of Indian academy of paediatrics. 1997 STA01: p 84–85.
- Giordano P, Galli M, Del Vecchio GL, Altomare M, Ruggere L, et al. Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassemia. Br J Hematol 1998;102 :903–906.
- Moratelli S, Sanctis V, Gemmati D, Serino MC, Mari R, Gamberini MR, Scapoli GL. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab 1998;11:915–921.
- Mondher Z, Herthem CM, Sondes M, et al. Lupus anticoagulant, anticardiolipin antibodies and anti beta2 GPI antibodies in patients witht thalassemia Poster presentation in APS-X. International Congress on antiphospholipid anti-bodies Sicily, Italy. Sep. 29—Oct. 3, 2002.
- Sinniah D, Ekert H, Bosco J, Nalhern L, Koe SL. Intracranial haemorrhage and circulating coagulation inhibitor in beta thalassemia major. J Paediatr 1981;99:700–703.
- Schlerder MA, Nachman RL,, Jaffe EA, Coleman MA. A clinical study of lupus anticoagulant. Blood 1976;48:499–509.
- Hunt JE, Mc Neil HP, Morgan GJ, Crameri RM, Krillis SA. A phospholipids-beta-2-GPI complex is antigen for antic-ardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1992;1(20):75–81.